Osmotic demyelination syndrome

American Journal of the Medical Sciences

Volumn 339, Issue 6, 2010, Pages 561-567

  King, Joshua D ^a   Rosner, Mitchell H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Hyponatremia; Osmotic demyelination syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; AQUAPORIN 1; AQUAPORIN 4; CHOLESTEROL; CORTICOSTEROID; DEXAMETHASONE; INOSITOL; POTASSIUM; POTASSIUM CHLORIDE; SODIUM; UREA;

ATAXIA; BRAIN SIZE; CAUSAL ATTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CRYSTALLOID; DEMYELINATING DISEASE; EPIDEMIOLOGICAL DATA; HOMEOSTASIS; HUMAN; HYPOKALEMIA; HYPONATREMIA; LIVER TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOLALITY; OSMOTIC DEMYELINATION SYNDROME; PARKINSONISM; PATHOGENESIS; PLASMAPHERESIS; PROGNOSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; QUADRIPLEGIA; REVIEW; RISK FACTOR; SODIUM BLOOD LEVEL;

EID: 77953357315     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181d3cd78     Document Type: Review

References (54)

1. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 1959;81:154-172
2. Pearce JM. Central pontine myelinolysis. Eur Neurol 2009;61:59-62.
3. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004; 75(suppl 3):iii22- 8.
4. Tomlinson BE, Pierides AM, Bradley WG. Central pontine myelinolysis. Two cases with associated electrolyte disturbance. Q J Med 1976;45:373-386
5. Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then and now. J Neuropathol Exp Neurol 2006;65:1-11.
6. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science 1981;211:1068-1070
7. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979;102:361-385
8. Love S. Demyelinating diseases. J Clin Pathol 2006;59:1151-1159
9. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol 2001;8:103-109
10. Murase T, Sugimura Y, Takefuji S, et al. Mechanisms and therapy of osmotic demyelination. Am J Med 2006;119:S69 -73.
11. Kim JG, Son YJ, Yun CH, et al. Thyroid transcription factor-1 facilitates cerebrospinal fluid formation by regulating aquaporin-1 synthesis in the brain. J Biol Chem 2007;282:14923-14931
12. Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr Nephrol 2007;22:778-784
13. Suzuki R, Okuda M, Asai J, et al. Astrocytes co-express aquaporin-1, -4, and vascular endothelial growth factor in brain edema tissue associated with brain contusion. Acta Neurochir Suppl (Wien) 2006;96: 398-401.
14. Pasantes-Morales H, Lezama RA, Ramos-Mandujano G, et al. Mechanisms of cell volume regulation in hypo-osmolality. Am J Med 2006;119:S4 -11.
15. Verbalis JG. Hypon atremia: epidemiology, pathophysiology, therapy. Curr Opin Nephrol Hypertens 1993;2:636-652
16. Ayus JC, Armstrong DL, Arieff AI. Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits. J Physiol 1996;492.1:243-255
17. de Pasquale M, Patlak CS, Cserr HF. Brain ion and volume regulation during acute hypernatremia in Brattleboro rats. Am J Physiol Renal Fluid Electrolyte Physiol 1989;256:F1059-66.
18. Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990;85:1427-1435
19. Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin and hypoxia. Am J Physiol Renal Physiol 2008;295:F619 -24.
20. Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res 1991;567:274-282
21. Adler S, Verbalis JG, Williams D. Effect of rapid correction of hyponatremia on the blood-brain barrier of rats. Brain Res 1995;679: 135-143
22. Lien YH. Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia. J Clin Invest 1995;95:1579-1586
23. Sterns RH, Silver SM. Brain volume regulation in response to hypoosmolality and its correction. Am J Med 2006;119:S12- 6.
24. Lohr JW. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med 1994;96: 408-413
25. Soupart A, Silver S, Schrooeder B, et al. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol 2002;13:1433-1441
26. Huang WY, Weng WC, Peng TI, et al. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail 2007;29:635-638
27. Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore) 1994;73:110-118
28. Burns JD, Kosa SC, Wijdicks EF. Central pontine myelinolysis in a patient with hyperosmolar hyperglycemia and consistently normal serum sodium. Neurocrit Care 2009;11:251-254
29. Cardenas JF, Bodensteiner JB. Osmotic demyelination syndrome as a consequence of treating hyperammonemia in a patient with ornithine transcarbamylase deficiency. J Child Neurol 2009;24:884-886
30. McComb RD, Pfeiffer RF, Casey JH, et al. Lateral pontine and extrapontine myelinolysis associated with hypernatremia and hyperglycemia. Clin Neuropathol 1989;8:284-288
31. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002; 47:3-10.
32. Newell KL, Kleinschmidt-DeMasters BK. Central pontine myelinolysis at autopsy: a twelve year retrospective analysis. J Neurol Sci 1996;142:134-139
33. Lee EM, Kang JK, Yun SC, et al. Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. Eur Neurol 2009;62:362-368
34. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009; 49:1610-1615
35. Menger H, Jorg J. Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol 1999;246:700-705
36. Miller GM, Baker HL Jr, Okazaki H, et al. Central pontine myelinolysis and its imitators: MR findings. Radiology 1988;168:795-802.
37. Howard SA, Barletta JA, Klufas RA, et al. Best cases from the AFIP: osmotic demyelination syndrome. Radiographics 2009;29:933-938
38. Dervisoglu E, Yegenaga I, Anik Y, et al. Diffusion magnetic resonance imaging may provide prognostic information in osmotic demyelination syndrome: report of a case. Acta Radiol 2006;47:208-212
39. Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007;120:S1-21.
40. Sanghvi SR, Kellerman PS, Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis 2007;50:673-680
41. Sterns RH, Hix JK. Overcorrection of hyponatremia is a medical emergency. Kidney Int 2009;76:587-589
42. Decaux G, Soupart A, Vassart G. Non-peptide arginine vasopressin antagonists-the vaptans. Lancet 2008;371:1624-1632
43. Madias NE. Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia. Am J Kidney Dis 2007;50:184-187
44. Schrier RW, Gross P, Gheorgihiade M, Berl T, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-2112
45. Walter KA. Conivaptan: new treatment for hyponatremia. Am J Health Syst Pharm 2007;64:1385-1395
46. Zeltser D, Rosansky S, van Rensburg H, et al. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007;27:447-457
47. Gankam Kengne F, Soupart A, Pochet R, et al. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 2009;76:614-621
48. Oya S, Tsutsumi K, Ueki K, et al. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology 2001;57:1931-1932
49. Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol 1999;51:383-386
50. Oh MS, Choi KC, Uribarri J, et al. Prevention of myelinolysis in rats by dexamethasone or colchicine. Am J Nephrol 1990;10:158-161
51. Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci 2003;326:25-30.
52. Bibl D, Lampl C, Gabriel C, et al. Treatment of central pontine myelinolysis with therapeutic plasmapheresis. Lancet 1999;353: 1155.
53. Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 1987;6:262-270
54. McCormick WF, Danneel CM. Central pontine myelinolysis. Arch Intern Med 1967;119:444-478